Vincent Cottin
Cottin, Vincent
Cottin, Vincent, 1967-....
![Sudoc [ABES], France](/viaf/images/flags/SUDOC.png "Sudoc [ABES], France")
VIAF ID: 295419383 (Personal)
Permalink: http://viaf.org/viaf/295419383
Preferred Forms
-
100 1 _
‡a
COTTIN, VINCENT.
-
100 1 _
‡a
Cottin, Vincent
-
100 1 _ ‡a Cottin, Vincent
-
100 1 _
‡a
Cottin, Vincent
-
100 1 _
‡a
Cottin, Vincent
-
100 1 _ ‡a Cottin, Vincent
-
100 1 _
‡a
Cottin, Vincent,
‡d
1967-....
-
100 0 _
‡a
Vincent Cottin
4xx's: Alternate Name Forms (2)
Works
| Title | Sources |
|---|---|
| Alteration of the surfactant protein A expression in idiopathic interstitial pneumonia. |
|
| Comparaison et impact des comorbidités dans la fibrose pulmonaire idiopathique et le syndrome emphysème-fibrose |
|
| Comparison of response to treatment and outcome in group 1 versus group 3 pulmonary hypertension in systemic sclerosis : data from the HYPID study, the French network for pulmonary arterial hypertension, and the French network for rare pulmonary diseases (Orphalung). |
|
| Dépistage des malformations artério-veineuses pulmonaires dans la maladie de Rendu-Osler : signification clinique des shunts intrapulmonaires et des micronodules pulmonaires isolés |
|
| Diffuse Pulmonary Non‐Amyloid Light‐Chain Deposition Disease: Phenotypes and Outcome. |
|
| DOSAGE URINAIRE DE L'EOSINOPHIL-DERIVED NEUROTOXIN (EDN) AU COURS DES PATHOLOGIES HYPEREOSINOPHILIQUES PULMONAIRES |
|
| La dyskinésie ciliaire primitive chez l'adulte : aspects descriptifs et évolutifs cliniques, fonctionnels et pronostiques |
|
| Effect of corticotherapy in unclassifiable interstitial lung disease. |
|
| Effet de la corticothérapie dans les pneumopathies interstitielles inclassables idiopathiques |
|
| Étude du phénotype pulmonaire des patients atteints de maladie pulmonaire par dépôts non amyloïde de chaines légères d'immunoglobuline |
|
| Étude en vie réelle de l'efficacité et de la tolérance du traitement anti-fibrosant chez les patients avec sclérodermie systémique |
|
| Orphan Lung Diseases : A Clinical Guide to Rare Lung Disease |
|
| Particularités de l'hypertension pulmonaire pré-capillaire du sujet âgé et très âgé |
|
| PAVM screening in hereditary hemorrhagic telangectasia : clinical significance of pulmonary micronodules at screening Chest CT and/or positive TTCE. |
|
| Phenotypic characterization of interstitial lung disease associated with mutations in SFTPC and ABCA3 in adults, anglais |
|
| Pneumopathie interstitielle et hypertension pulmonaire au cours de la sclérodermie systémique dans l'étude HYPID |
|
| Pulmonary Arterial Hypertension Associated With Systemic Lupus Erythematosus: Results From the French Pulmonary Hypertension Registry |
|
| [Pulmonary hypertension in interstitial lung diseases: diagnostic and therapeutic approach in 2011?] |
|
| Pulmonary hypertension in lymphangioleiomyomatosis: characteristics in 20 patients |
|
| [Pulmonary MALT lymphoma] |
|
| Pulmonary manifestations of systemic diseases |
|
| [Pulmonary rheumatoid nodule]. |
|
| Pulmonary Vein Varices Are Syndromic Features in Turner Syndrome |
|
| Rare (pulmonary) disease day: "feeding the breath, energy for life!". |
|
| Real-life experience of antifibrotic therapy in patients with progressive pulmonary fibrosis, anglais |
|
| Recent advances in the pathobiology and clinical management of lymphangioleiomyomatosis |
|
| Regulator of telomere length 1 (RTEL1) mutations are associated with heterogeneous pulmonary and extra-pulmonary phenotypes |
|
| [Relapsing pneumothorax in a young woman, revealing lymphangioleiomyomatosis] |
|
| [Rendu-Osler disease] |
|
| The Respiratory System in Autoimmune Vascular Diseases |
|
| Response to Letter Regarding Article, “Mitomycin-Induced Pulmonary Veno-Occlusive Disease: Evidence From Human Disease and Animal Model” |
|
| Review of IPF diagnosis and management recommendations in Europe |
|
| Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension |
|
| Risk factors for disease progression in idiopathic pulmonary fibrosis |
|
| Risk of Direct Oral Anticoagulant Bioaccumulation in Patients with Pulmonary Hypertension. |
|
| Role of atmospheric pollution on the natural history of idiopathic pulmonary fibrosis. |
|
| [Saddle nose deformity] |
|
| Safety of right heart catheterization for pulmonary hypertension in very elderly patients |
|
| Santé publique Thérapeutique / Médecine légale / Médecine du travail / LCA / Maladies rares |
|
| Screening for lung cancer and idiopathic pulmonary fibrosis: killing two birds with one stone |
|
| Severe Prolonged Cough as Presenting Manifestation of FIP1L1-PDGFRA+ Chronic Eosinophilic Leukaemia: A Widely Ignored Association. |
|
| Severe pulmonary hypertension associated with COPD: hemodynamic improvement with specific therapy |
|
| Signalisation intracellulaire par le récepteur CD120a pour le TNFα : rôle de la phosphorylation du domaine intracellulaire de CD120a dans la régulation des effets biologiques cellulaires du TNFα |
|
| Specific molecular events during lepidic pulmonary adenocarcinomas in humans and sheep. |
|
| Spectrum and prognosis of ANCA-associated vasculitis-related bronchiectasis: data from 61 patients |
|
| Spectrum of Fibrotic Lung Diseases |
|
| Spontaneous pneumomediastinum associated with pneumorachis. |
|
| Statin Therapy and Outcomes in Trials of Nintedanib in Idiopathic Pulmonary Fibrosis. |
|
| Subclinical interstitial lung disease: no place for crackles? |
|
| Subclinical venous access infection and clinical worsening in pulmonary arterial hypertension. |
|
| Survey of Physician's Knowledge, Attitudes, and Practices Regarding Idiopathic Pulmonary Fibrosis in Turkey |
|
| Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era. |
|
| Symptomatic muscular sarcoidosis: Lessons from a nationwide multicenter study. |
|
| Synchronous small-cell lung cancer and gastrointestinal stromal tumor: a case report |
|
| Le syndrome emphysème-fibrose : aspects évolutifs, pronostic et complications |
|
| The syndrome of combined pulmonary fibrosis and emphysema |
|
| Syndrome of pleural and retrosternal "bridging" fibrosis and retroperitoneal fibrosis in patients with asbestos exposure |
|
| Targeting interleukin-13 in idiopathic pulmonary fibrosis: from promising path to dead end |
|
| Therapeutic effects of nintedanib are not influenced by emphysema in the INPULSIS trials |
|
| Thoracic manifestations of segmental neurofibromatosis |
|
| The threat in chronic lung diseases: acute exacerbations |
|
| Traité de médecine. |
|
| Translation and validation of the King's Brief Interstitial Lung Disease (K-BILD) questionnaire in French, Italian, Swedish, and Dutch. |
|
| Treatment of idiopathic inflammatory myositis associated interstitial lung disease: A systematic review and meta-analysis |
|
| Treatment of idiopathic pulmonary fibrosis with etanercept: an exploratory, placebo-controlled trial. |
|
| Treatment of progressive fibrosing interstitial lung diseases: a milestone in the management of interstitial lung diseases |
|
| Understanding the priorities for women diagnosed with lymphangioleiomyomatosis: a patient perspective |
|
| Unusual bilateral acinar nodules: case for diagnosis |
|
| Upfront triple combination therapy in pulmonary arterial hypertension: a pilot study |
|
| Use of Biologics to Treat Relapsing and/or Refractory Eosinophilic Granulomatosis with Polyangiitis: data from a European Collaborative Study |
|
| Usual interstitial pneumonia end-stage features from explants with radiologic and pathological correlations. |
|
| Usual interstitial pneumonia in ANCA-associated vasculitis: A poor prognostic factor |
|
| Validation of multidisciplinary diagnosis in IPF. |
|
| Vinblastine chemotherapy in adult patients with langerhans cell histiocytosis: a multicenter retrospective study |
|
| [Wegener's granulomatosis] |
|
| When to stop in the quest of formes frustes of connective tissue disease? |
|
| Which Biopsy to Diagnose Interstitial Lung Disease? A Call for Evidence and Unity |
|
| Who and what should we rely on in early diagnosis of idiopathic pulmonary fibrosis? |
|
| Whole exome sequencing in three families segregating a pediatric case of sarcoidosis. |
|
| Whole lung lavage therapy for pulmonary alveolar proteinosis: a global survey of current practices and procedures. |
|
| Widening the landscape of heritable pulmonary hypertension mutations in paediatric and adult cases |
|
